Divided Fed. Circ. Nixes Rehearing Of Mirapex Spat
A federal appeals court has refused to rehear a case that gave a win to pharmaceutical company Boehringer Ingelheim International GmbH and firmed up the safe harbor provisions of 35 U.S.C....To view the full article, register now.
Already a subscriber? Click here to view full article